It triggers the release of growth hormone without significantly impacting other hormones such as cortisol or prolactin, which minimizes side effects
By combining a short-acting Growth Hormone-Releasing Hormone (GHRH) analog with a highly selective Growth Hormone Secretagogue Receptor (GHSR) agonist, researchers can evaluate physiologic GH pulsatility, receptor interactions, endocrine signaling, and downstream biomarker responses under controlled laboratory conditions
It may also support fertility, exercise performance, and help manage oxidative stress or chronic fatigue conditions
Visual analysis was conducted through the microbiological letter platform ( 2.2.6 Molecular docking Proteins encoded by the core target genes were selected as molecular docking proteins, with LC serving as the binding ligand
and 5.14 kg and 1.89 kg/m 2 at 6 months [43]
Begin your plan Your prescription and dose are personalized if approved